IPV 疫苗市场（按疫苗品牌、分销管道和地区）—市场规模、份额、前景和机会分析（2025-2032）

2025 年全球 IPV 疫苗市场规模估计为 1.999 亿美元，预计到 2032 年将达到 3.585 亿美元，2025 年至 2032 年的复合年增长率为 8.7%。

数字。 2025年IPV疫苗各地区市场占有率（%）

灭活脊髓灰质炎疫苗（IPV）也称为索尔克疫苗。脊髓灰质炎疫苗有两种：灭活脊髓灰质炎疫苗和口服脊髓灰质炎疫苗。 IPV 疫苗通常透过注射到手臂或腿部进行接种。

对鸡蛋或链霉素等药物过敏的人不应接受 IPV 注射。只有当疫苗接种者正在接受长期类固醇治疗、患有癌症、正在接受化疗或家中有未免疫的成年人时，才会进行 IPV。

预计到 2025 年全球 IPV 疫苗市场规模将达到 1.999 亿美元，到 2032 年将达到 3.585 亿美元，预测期内复合年增长率为 8.7%。

市场动态

为了防止脊髓灰质炎的爆发，各国政府正在采取倡议提高人们对疫苗接种的认识。公共部门组织已经实施了利润丰厚的疫苗接种计划，为贫困人口提供疫苗接种，预计这将为不久的将来全球灭活脊髓灰质炎疫苗 (IPV) 市场的成长创造非常有利的环境。例如，2020年9月，加纳卫生服务局（GHS）启动了一系列脊髓灰质炎疫苗接种/免疫宣传活动，以防止病毒在高风险地区传播。脊髓灰质炎疫苗接种宣传活动正在加纳所有地区为 2016 年 1 月至 2018 年 6 月期间出生的所有儿童接种灭活脊髓灰质炎疫苗 (IPV)。

研究的主要特点

• 本报告详细分析了预测期（2025-2032 年）全球 IPV 疫苗市场规模和年复合成长率（CAGR%），假设 2024 年为基准年。
• 它揭示了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
• 全球 IPV 疫苗市场的主要企业根据公司概况、业绩、产品系列、市场影响、分销策略、关键发展、策略和未来计划等参数进行分析。
• 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
• IPV 疫苗市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
• 全球 IPV 疫苗市场分析中使用的各种策略矩阵将有助于相关人员做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件

第二章 市场概述

• 报告描述
  • 市场定义和范围
• 执行摘要
• 市场机会蓝图

第三章 关键见解

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• PEST分析
• 波特分析
• 公司市场占有率分析
• 进出口分析
• 监管情景
• 定价分析
• COVID-19影响分析
• 流行病学
• 国家医疗费用支出
• 各国疫苗覆盖率
• 生产能力
• 经销商状况
• 投资与资金筹措
• 竞争格局
• 热图分析

4. 2020-2032 年全球 IPV 疫苗市场（以疫苗品牌）

• 介绍
• 脊髓灰质炎疫苗（PFS/SD）
• 沙尼普
• Orix
• IPOL/IMOVAX
• 灭蚁灵

5. 2020-2032 年全球 IPV 疫苗市场（依疫苗类型）

• 介绍
• 联合疫苗
• 单一疫苗

6. 2020-2032 年全球 IPV 疫苗市场（管瓶瓶型）

• 介绍
• 单剂量管瓶
• 5剂量管瓶
• 10剂量管瓶

7. 2020-2032 年全球 IPV 疫苗市场（按分销管道）

• 介绍
• 公共
• 私人的

8. 2020-2032 年全球 IPV 疫苗市场（按地区）

• 介绍
• 北美洲
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东
• 非洲

第九章 竞争态势

10. 公司简介-全球IPV疫苗市场

• Sanofi
• Serum Institute of India Pvt. Ltd.
• Bharat BIoTech
• Merck & Co., Inc.
• GlaxoSmithKline
• AJ Vaccines A/S
• Panacea BIoTec
• Biken
• Sinopharm Group Co. Ltd.
• Nanolek
• IMBCAMS
• Sinovac BIoTech
• LG Chem
• Beijing Minhai Biological Technology Co., Ltd.
• Biological E Limited
• Section 10
• 兴衰
• 分析师观点
• 一致的机会地图

第 11 章参考文献与调查方法

• 参考
• 调查方法

Global Ipv Vaccines Market is estimated to be valued at USD 199.9 Mn in 2025 and is expected to reach USD 358.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.

Figure. Ipv Vaccines Market Share (%), By Region 2025

Inactivated polio vaccine (IPV) is also known as Salk vaccine. For the vaccination against polio there are two vaccines available: inactivated polio vaccine and oral polio vaccine. The IPV vaccine is mostly given in arm or leg as a shot.

Individuals who are allergic to eggs or the drugs such as streptomycin should not receive the injectable IPV. The IPV is only given if the vaccine recipient is on steroid therapy for long-term, has cancer, or is on ongoing process of chemotherapy or there is any unimmunized adult in house.

Global IPV vaccines market was valued at USD 199.9 Mn in 2025 and is expected to increase to US$ 358.5 Mn by 2032, registering a CAGR of 8.7% over the forecast period.

Market Dynamics

Various governments have taken initiatives to increase awareness regarding vaccination to prevent occurrence of polio among the population. Public introduced beneficial immunization programs to provide vaccination to poor people, which is expected to create a highly conducive environment for growth of the Global Inactivated Polio Vaccines Market (IPV) in the near future. For instance, in September 2020, the Ghana Health Service (GHS), launched series of polio vaccination/immunization campaign to prevent spreading of the virus in high risk areas. The immunization polio vaccination campaign will use the inactivated polio vaccine (IPV) to immunize all the children born from January 2016 to June 2018 in all districts across Ghana.

Key features of the study:

• This report provides in-depth analysis of the Global IPV vaccines market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Global IPV vaccines market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include GlaxoSmithKline Plc, Sanofi S.A., Serum Institute of India Pvt. Ltd., PT Bio Farma, and AJ Vaccines
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The IPV vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global IPV vaccines market

Detailed Segmentation:

• Global IPV Vaccines Market, by Vaccine Brand:
  • Poliovac (Pfs/Sd)
  • Shanipv
  • Poliorix
  • Ipol/Imovax
  • Polymilex
• Global IPV Vaccines Market, by Distribution Channel:
  • Private
  • Public
• Global IPV Vaccines Market, by Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • GlaxoSmithKline Plc
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • PT Bio Farma
  • AJ Vaccines

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Vaccine Brand
  • Market Snapshot, By Vaccine Type
  • Market Snapshot, By Vial Type
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
  • Market Scenario - Conservative, Likely, Opportunistic
• Market Opportunity Map

3. Key Insights

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Pest Analysis
• Porters Analysis
• Company Market Share Analysis
• Import-Export Analysis
• Regulatory Scenario
• Pricing Analysis
• COVID-19 Impact Analysis
• Epidemiology
• Healthcare Spending, by Country
• Vaccination Rate, by Country
• Manufacturing Capacities
• Distributors Landscape
• Investments & Funding
• Competitive Snapshot
• Heat Map Analysis

4. Global IPV Vaccines Market, By Vaccine Brand, 2020 - 2032 (US$ Million)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032
  • Market Y-o-Y Growth Comparison (%), 2020 - 2032
  • Segment Trends
• POLIOVAC (PFS/SD), 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)
• SHANIPV, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)
• POLIORIX, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)
• IPOL/IMOVAX, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)
• POLYMILEX, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)

5. Global IPV Vaccines Market, By Vaccine Type, 2020 - 2032 (US$ Million)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032
  • Market Y-o-Y Growth Comparison (%), 2020 - 2032
  • Segment Trends
• Combination Vaccine, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)
• Single Vaccine, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)

6. Global IPV Vaccines Market, By Vial Type, 2020 - 2032 (US$ Million)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032
  • Market Y-o-Y Growth Comparison (%), 2020 - 2032
  • Segment Trends
• 1 Dose Vial, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)
• 5 Dose Vial, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)
• 10 Dose Vial, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)

7. Global IPV Vaccines Market, By Distribution Channel, 2020 - 2032 (US$ Million)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032
  • Market Y-o-Y Growth Comparison (%), 2020 - 2032
  • Segment Trends
• Public, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)
• Private, 2020 - 2032(US$ Million)
  • Introduction
  • Market Size and Forecast, 2020 - 2032, (US$ Million)

8. Global IPV Vaccines Market, By Region, 2020 - 2032 (US$ Million)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, (US$ Million)
  • Market Y-o-Y Growth Comparison (%), 2025 - 2032, (US$ Million)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest Of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Asean
    • Rest Of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
    • GCC
    • Israel
    • Rest Of The Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, (US$ Million)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Competitive Snapshot
• What Market Participants are Saying?
• Competitive Dashboard
• Company Market Share Analysis, 2025 - Global

10. Company Profiles - Global IPV Vaccines Market

• Sanofi*
  • Company Overview
  • Product/Service Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategic Overview
• Serum Institute of India Pvt. Ltd.
• Bharat Biotech
• Merck & Co., Inc.
• GlaxoSmithKline
• AJ Vaccines A/S
• Panacea Biotec
• Biken
• Sinopharm Group Co. Ltd.
• Nanolek
• IMBCAMS
• Sinovac Biotech
• LG Chem
• Beijing Minhai Biological Technology Co., Ltd.
• Biological E Limited.
• Section 10: Wheel of Fortune
• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact